与富血小板血治疗相关的不良事件以及未来需要解决的问题
1Medical Technology Innovation Center, Juntendo University, A-Bld, 3F, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 1138421, Japan.
Regenerative therapy
|August 5, 2024
概括
用于治疗和治疗疼痛的富血小板血 (PRP) 治疗具有感染和炎症等风险. 需要进一步的研究来澄清PRP治疗的安全性,并建立更好的随访系统.
科学领域:
- 再生医学是一种再生医学.
- 生物技术是生物技术.
- 临床安全 临床安全
背景情况:
- 富于血小板的血 (PRP) 是从自身血液中衍生出来的,用于治疗目的的血小板度.
- 在各种医疗学科中,PRP疗法广泛应用于伤口愈合和疼痛管理.
- 尽管PRP治疗的临床使用,但其整体的安全性概况仍然不完全理解.
研究的目的:
- 审查和讨论与PRP治疗相关的固有风险和当前问题.
- 在不同医学领域调查与PRP治疗相关的报道不良事件 (AEs).
- 确定关于PRP安全的知识差距,并为未来的研究方向提供信息.
主要方法:
- 在PubMed上进行了全面的文献搜索,寻找详细介绍PRP治疗的副作用的文章.
- 搜索涵盖了从数据库创建到2024年1月的出版物.
- 该审查综合了从案例报告和其他有关PRP相关AEs的相关研究中的发现.
主要成果:
- PRP疗法与各种AE有关,包括术后感染,失明,炎症,过敏反应和结节形成.
- 手术后感染是最频繁报告的AE.
- 血液采集,处理或施用期间可能存在的微生物污染是感染的可疑原因,因为PRP不能被消毒.
- 需要进一步阐明PRP加工中存在微生物污染风险的具体阶段.
结论:
- 在PRP治疗期间预防微生物污染至关重要,需要确定风险因素.
- 为了确定PRP治疗的有效性和风险,以及强大的后续系统,需要进一步的研究.
- 需要高质量的证据和详细的验证来确认PRP治疗和报告的副作用之间的因果关系,超越病例报告.
相关概念视频
Formation of the Platelet Plug
5.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.5K
Disorders of Hemostasis
768
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
768
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
502
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
502
Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
Introduction to Hemostasis
6.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.8K


